Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Faustine Ravon

Showing results (1-10 of 4) with videos related to

Pageof 1
Sort By:
Microorganisms|March 2, 2019
<i>Mycobacterium smegmatis</i> But Not <i>Mycobacterium avium</i> subsp. <i>hominissuis</i> Causes Increased Expression of the Long Non-Coding RNA MEG3 in THP-1-Derived Human Macrophages and Associated Decrease of TGF-βSoroush Sharbati, Faustine Ravon, Ralf Einspanier, et al.
Journal of Applied Toxicology : JAT|August 23, 2022
In vitro and in vivo local tolerability of a synergistic anti-tuberculosis drug combination intended for pulmonary deliveryFaustine Ravon, Elena Menchi, Coralie Lambot, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2019
Isoniazid Bactericidal Activity Involves Electron Transport Chain PerturbationSheng Zeng, Karine Soetaert, Faustine Ravon, et al.
Pharmaceutics|June 27, 2025
Assessment of Innovative Dry Powders for Inhalation of a Synergistic Combination Against <i>Mycobacterium tuberculosis</i> in Infected Macrophages and MiceFaustine Ravon, Emilie Berns, Isaline Lambert, et al.
Pageof 1

Showing results (1-10 of 4) with videos related to

Sort By:
Pageof 1
Microorganisms|March 2, 2019
<i>Mycobacterium smegmatis</i> But Not <i>Mycobacterium avium</i> subsp. <i>hominissuis</i> Causes Increased Expression of the Long Non-Coding RNA MEG3 in THP-1-Derived Human Macrophages and Associated Decrease of TGF-βSoroush Sharbati, Faustine Ravon, Ralf Einspanier, et al.
Journal of Applied Toxicology : JAT|August 23, 2022
In vitro and in vivo local tolerability of a synergistic anti-tuberculosis drug combination intended for pulmonary deliveryFaustine Ravon, Elena Menchi, Coralie Lambot, et al.
Antimicrobial Agents and Chemotherapy|January 16, 2019
Isoniazid Bactericidal Activity Involves Electron Transport Chain PerturbationSheng Zeng, Karine Soetaert, Faustine Ravon, et al.
Pharmaceutics|June 27, 2025
Assessment of Innovative Dry Powders for Inhalation of a Synergistic Combination Against <i>Mycobacterium tuberculosis</i> in Infected Macrophages and MiceFaustine Ravon, Emilie Berns, Isaline Lambert, et al.
Pageof 1